Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Published in: Current Neurology and Neuroscience Reports 3/2014

01-03-2014 | Neuro-Ophthalmology (A Kawasaki, Section Editor)

Update on the Surgical Management of Idiopathic Intracranial Hypertension

Authors: Nisha Mukherjee, M. Tariq Bhatti

Published in: Current Neurology and Neuroscience Reports | Issue 3/2014

Login to get access

Abstract

Idiopathic intracranial hypertension (IIH) is a disorder of elevated intracranial pressure due to an unknown cause. In most cases, IIH can be managed with medical therapy and weight reduction. Surgical treatment of IIH is reserved for patients who cannot tolerate medical therapy, are nonadherent to medical therapy, develop progressive symptoms despite maximal medical therapy, or present with fulminant visual loss. To date, there has been no randomized controlled trial to evaluate the surgical treatment of IIH, and our current knowledge of the efficacy and complications of these procedures is based on retrospective and observational studies. This review discusses the indications for surgical intervention in IIH and provides an overview of the recently published data on the efficacy and complications of these interventions. A surgical management algorithm is also presented to guide the clinician when evaluating a patient with IIH.
Literature
1.
Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol. 2004;24(2):138–45.PubMedCrossRef
2.
Thambisetty M et al. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68(3):229–32.PubMedCrossRef
3.
Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep. 2008;8(2):87–93.PubMedCrossRef
4.
5.
Feldon SE. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus. 2007;23(5):E6.PubMedCrossRef
6.
Alsuhaibani AH et al. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology. 2011;118(2):412–4.PubMedCrossRef
7.
8.
Corbett JJ et al. Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach. Arch Ophthalmol. 1988;106(10):1391–7.PubMedCrossRef
9.
Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol. 1989;46(10):1049–51.PubMedCrossRef
10.••
Spitze A et al. Optic nerve sheath fenestration vs cerebrospinal diversion procedures: what is the preferred surgical procedure for the treatment of idiopathic intracranial hypertension failing maximum medical therapy? J Neuroophthalmol. 2013;33(2):183–8. This article discusses the merits of ONSF versus CSF diversion in the management of IIH in a point–counterpoint format by several neuro-ophthalmologists. Major case reports and case series on both ONSF and CSF diversion are reviewed.PubMedCrossRef
11.
Brazis PW. Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia. 2008;28(12):1361–73.PubMedCrossRef
12.
Sergott RC, Savino PJ, Bosley TM. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol. 1988;106(10):1384–90.PubMedCrossRef
13.
Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000;107(10):1907–12.PubMedCrossRef
14.
Thuente DD, Buckley EG. Pediatric optic nerve sheath decompression. Ophthalmology. 2005;112(4):724–7.PubMedCrossRef
15.
Wilkes BN, Siatkowski RM. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration. J Neuroophthalmol. 2009;29(4):281–3.PubMedCrossRef
16.
Gellrich NC et al. Degeneration of retinal ganglion cells after optic nerve sheath fenestration in an experimental rat model. J Neuroophthalmol. 2009;29(4):275–80.PubMedCrossRef
17.
Curry Jr WT, Butler WE, Barker 2nd FG. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery. 2005;57(1):97–108, discussion 97-108.PubMedCrossRef
18.•
Tarnaris A et al. Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site: a single centre experience. Clin Neurol Neurosurg. 2011;113(6):477–9. A retrospective review of 34 patients with IIH who underwent CSF diversion with a mean follow-up of 31.8 months. VPS patients had fewer complications than LPS patients.PubMedCrossRef
19.
Abubaker K et al. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts—case series and literature review. Br J Neurosurg. 2011;25(1):94–9.PubMedCrossRef
20.•
Sinclair AJ et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia. 2011;31(16):1627–33. A 10-year retrospective review of 53 patients who underwent CSF diversion (predominantly LPS) for management of IIH. Visual outcomes significantly improved after CSF shunting; however, headache persisted in most patients after surgery.PubMedCrossRef
21.
Kandasamy J et al. Electromagnetic stereotactic ventriculoperitoneal CSF shunting for idiopathic intracranial hypertension: a successful step forward? World Neurosurg. 2011;75(1):155–60, discussion 32-3.PubMedCrossRef
22.
Nadkarni TD, Rekate HL, Wallace D. Concurrent use of a lumboperitoneal shunt with programmable valve and ventricular access device in the treatment of pseudotumor cerebri: review of 40 cases. J Neurosurg Pediatr. 2008;2(1):19–24.PubMedCrossRef
23.
McGirt MJ et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg. 2004;101(4):627–32.PubMedCrossRef
24.
Karabatsou K et al. Lumboperitoneal shunts: are the complications acceptable? Acta Neurochir (Wien). 2004;146(11):1193–7.CrossRef
25.
Higgins JN et al. Venous sinus stenting for refractory benign intracranial hypertension. Lancet. 2002;359(9302):228–30.PubMedCrossRef
26.••
Puffer RC, Mustafa W, Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature. J Neurointerv Surg. 2013;5(5):483–6. A review of the current literature on venous sinus stenting for management of IIH. A total of 143 patients were analyzed. After venous sinus stenting, 88 % of patients had improvement in headache, 97 % had resolution of papilledema, and 87 % had improvement or resolution of visual symptoms.PubMedCrossRef
27.•
Radvany MG et al. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis. J Neuroophthalmol. 2013;33(2):117–22. The outcome results of 12 patients with IIH and transverse sinus stenosis who underwent venous sinus stenting after medical therapy had failed are presented. Approximately 90 % of patients had improvement in visual function after stenting, and 58 % of patients had improvement in headache. Venous sinus stenting in patients with evidence of transverse sinus stenosis has a significant positive effect on visual dysfunction.PubMedCrossRef
28.
29.
Ahmed RM et al. Transverse sinus stenting for pseudotumor cerebri: a cost comparison with CSF shunting. AJNR Am J Neuroradiol. 2013. doi:10.​3174/​ajnr.​A3806.
30.
Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch Intern Med. 1974;133(5):802–7.PubMedCrossRef
31.
Johnson LN et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105(12):2313–7.PubMedCrossRef
32.
Kupersmith MJ et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50(4):1094–8.PubMedCrossRef
33.
Wong R et al. Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol. 2007;7:15.PubMedCentralPubMedCrossRef
34.
Fridley J et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011;114(1):34–9.PubMedCrossRef
35.
Egan RJ et al. The effects of laparoscopic adjustable gastric banding on idiopathic intracranial hypertension. Obes Surg. 2011;21(2):161–6.PubMedCrossRef
36.
Maggard-Gibbons M et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309(21):2250–61.PubMedCrossRef
37.
Kim MK et al. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass. Diabetes Metab Res Rev. 2012;28(5):439–46.PubMedCrossRef
38.
Juhasz-Pocsine K et al. Neurologic complications of gastric bypass surgery for morbid obesity. Neurology. 2007;68(21):1843–50.PubMedCrossRef
39.
Sinha MK et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int. 2007;72(1):100–7.PubMedCrossRef
40.
Slater GH et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8(1):48–55, discussion 54-5.PubMedCrossRef
41.
Lee WJ et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52.PubMedCrossRef
42.
43.
Scopinaro N et al. Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI < 35 kg/m2. Obes Surg. 2007;17(2):185–92.PubMedCrossRef
44.
Mocco J et al. Aggressive cranial vault decompression for cranial hyperostosis: technical case report of two cases. Neurosurgery. 2005;57(1 Suppl):E212, discussion E212.PubMedCrossRef
45.
Ellis JA et al. Internal cranial expansion surgery for the treatment of refractory idiopathic intracranial hypertension. J Neurosurg Pediatr. 2012;10(1):14–20.PubMedCrossRef
Metadata
Title
Update on the Surgical Management of Idiopathic Intracranial Hypertension
Authors
Nisha Mukherjee
M. Tariq Bhatti
Publication date
01-03-2014
Publisher
Springer US
Published in
Current Neurology and Neuroscience Reports / Issue 3/2014
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-014-0438-8

Other articles of this Issue 3/2014

Current Neurology and Neuroscience Reports 3/2014 Go to the issue

Headache (R Halker, Section Editor)

Hemicrania Continua

Sleep (M Thorpy, M Billiard, Section Editors)

Dreaming and Offline Memory Consolidation

Nerve and Muscle (L Weimer, Section Editor)

Distal Myopathies

Sleep (M Thorpy, M Billiard, Section Editors)

Epigenetics of Sleep and Chronobiology

Nerve and Muscle (L Weimer, Section Editor)

FAP Neuropathy and Emerging Treatments